BioCentury
ARTICLE | Company News

Dynamis, Development Center for Biotechnology deal

January 28, 2002 8:00 AM UTC

Dynamis and the center formed a joint venture to develop Dynamis's Dyn 12 small molecule inhibitor of amadorase, an enzyme involved in the formation of 3-deoxyglucosone (3DG), which is associated with...